open access

Vol 79, No 5 (2011)
ORIGINAL PAPERS
Published online: 2011-08-22
Submitted: 2013-02-22
Get Citation

Costs of chronic obstructive pulmonary disease in patients receiving specialist outpatient care in Poland

Karina Jahnz-Różyk, Tomasz Targowski, Sławomir From, Tomasz Faluta, Łukasz Borowiec
Pneumonol Alergol Pol 2011;79(5):337-342.

open access

Vol 79, No 5 (2011)
ORIGINAL PAPERS
Published online: 2011-08-22
Submitted: 2013-02-22

Abstract

Introduction: Chronic obstructive pulmonary disease (COPD) is one of the leading causes of death in Poland and worldwide. Cost-of-illness studies (analysing total, direct and indirect costs) are studies aimed to determine the economic burden of a disease. Acute exacerbations and hospitalisation are the major cost drivers in COPD. The aim of the study was to estimate the direct costs of COPD treatment in the setting of specialist outpatient care from the societal perspective.
Material and methods: Chronic obstructive pulmonary disease costs were estimated from a compilation of data: medical records of patients managed at 8 specialist outpatient clinics and 5 teaching hospitals in Poland between 2007 and 2008. The direct costs, resulting from chronic treatment and treatment of acute exacerbations in the outpatient setting, were calculated using the bottom-up approach on the basis of data collected by pulmonary specialists at outpatient clinics. The mean cost of acute exacerbation managed in the inpatient setting was derived from a multicentre Polish study in which five clinical centres participated.
Results: The total cost per patient per year was 4027.82 zlotys (1007 euro) and included the cost of chronic treatment in the amount of 2423.57 zlotys (606 euro) plus the cost of treatment of an acute exacerbation in the outpatient setting in the amount of 421.16 zlotys (105 euro) plus the cost of treatment of an acute exacerbation in the inpatient setting in the amount of 1183.09 zlotys (296 euro).
Conclusion: Treatment of COPD in poses a considerable economic burden on the Polish society.
Pneumonol. Alergol. Pol. 2011; 79, 5: 337–342

Abstract

Introduction: Chronic obstructive pulmonary disease (COPD) is one of the leading causes of death in Poland and worldwide. Cost-of-illness studies (analysing total, direct and indirect costs) are studies aimed to determine the economic burden of a disease. Acute exacerbations and hospitalisation are the major cost drivers in COPD. The aim of the study was to estimate the direct costs of COPD treatment in the setting of specialist outpatient care from the societal perspective.
Material and methods: Chronic obstructive pulmonary disease costs were estimated from a compilation of data: medical records of patients managed at 8 specialist outpatient clinics and 5 teaching hospitals in Poland between 2007 and 2008. The direct costs, resulting from chronic treatment and treatment of acute exacerbations in the outpatient setting, were calculated using the bottom-up approach on the basis of data collected by pulmonary specialists at outpatient clinics. The mean cost of acute exacerbation managed in the inpatient setting was derived from a multicentre Polish study in which five clinical centres participated.
Results: The total cost per patient per year was 4027.82 zlotys (1007 euro) and included the cost of chronic treatment in the amount of 2423.57 zlotys (606 euro) plus the cost of treatment of an acute exacerbation in the outpatient setting in the amount of 421.16 zlotys (105 euro) plus the cost of treatment of an acute exacerbation in the inpatient setting in the amount of 1183.09 zlotys (296 euro).
Conclusion: Treatment of COPD in poses a considerable economic burden on the Polish society.
Pneumonol. Alergol. Pol. 2011; 79, 5: 337–342
Get Citation

Keywords

chronic obstructive pulmonary disease; direct costs; Poland

About this article
Title

Costs of chronic obstructive pulmonary disease in patients receiving specialist outpatient care in Poland

Journal

Advances in Respiratory Medicine

Issue

Vol 79, No 5 (2011)

Pages

337-342

Published online

2011-08-22

Bibliographic record

Pneumonol Alergol Pol 2011;79(5):337-342.

Keywords

chronic obstructive pulmonary disease
direct costs
Poland

Authors

Karina Jahnz-Różyk
Tomasz Targowski
Sławomir From
Tomasz Faluta
Łukasz Borowiec

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

Czasopismo Pneumonologia i Alergologia Polska dostęne jest również w Ikamed - księgarnia medyczna

Wydawcą serwisu jest "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail: viamedica@viamedica.pl